Avalyn Pharma Inc.
AVLN
$30.71
$1.735.97%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 123.13M | 110.63M | |||
| Total Receivables | 253.00K | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 864.00K | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 5.74M | -- | |||
| Total Current Assets | 129.99M | -- | |||
|
|
|||||
| Total Current Assets | 129.99M | -- | |||
| Net Property, Plant & Equipment | 2.68M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 3.00M | -- | |||
| Total Assets | 135.66M | -- | |||
|
|
|||||
| Total Accounts Payable | 3.15M | -- | |||
| Total Accrued Expenses | 8.13M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 507.00K | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | 11.79M | -- | |||
|
|
|||||
| Total Current Liabilities | 11.79M | -- | |||
| Long-Term Debt | 14.81M | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 1.09M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 27.69M | -- | |||
|
|
|||||
| Common Stock & APIC | 27.97M | -- | |||
| Retained Earnings | -292.23M | -- | |||
| Treasury Stock & Other | 12.00K | -- | |||
| Total Common Equity | -264.25M | -174.52M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 372.22M | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 372.22M | 290.30M | |||
|
|
|||||
| Total Common Equity | -264.25M | -174.52M | |||
| Total Preferred Equity | 372.22M | 290.30M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 107.98M | 115.78M | |||
|
|
|||||